Company: TELO
Filing Date: 2025-11-20
Form Type: PREM14A
Source: 0001493152-25-024463
Chunk: 128

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-20
Form: PREM14A
Chunk 128
---
                                                                                                  
 power over the shares held by each trust, and as such, is deemed to have beneficial ownership (as determined under Section 13(d)                                                                                                 
 of the Exchange Act) of the securities held by each trust. Mr. Jonnie R. Williams, Sr., our founder and the settlor of the Bayshore Trust, does not have voting or dispositive power over the shares held by the Bayshore Trust. |

| (4) | Acting                                                                            
 as trustee of the John Paul DeJoria Family Trust, and in his individual capacity. |

| 75 |

<div align='center'>FUTURE STOCKHOLDER PROPOSALS</div>

TELO’s stockholders may submit proposals on matters appropriate for stockholder action at meetings of TELO’s stockholders in accordance with Rule 14a-8 promulgated under the Exchange Act. For such proposals to be included in TELO’s proxy materials relating to TELO’s 2026 annual meeting of stockholders, all applicable requirements of Rule 14a-8 must be satisfied and such proposals must be received by TELO no later than April 10, 2026. However, if TELO’s 2026 annual meeting of stockholders is not held between and September 8, 2025, then the deadline will be a reasonable time prior to the time TELO begins to print and mail its proxy materials.

To be considered for inclusion as a director nominee in the proxy statement relating to our 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”), the notice must comply with Rule 14a-9 under the Exchange Act, and include certain information concerning the nominee or proposal, as the case may be, and information concerning the proposing or nominating stockholder’s ownership of and agreements related to our stock, the nominee’s name and qualifications for Board membership, information regarding the candidate as would be required to be included in a proxy statement filed pursuant to SEC regulations, and a written indication by the recommended candidate of her or his willingness to serve. For all business proposed to be brought to the 2025 Annual Meeting other than director nominations, a proposing stockholder’s notice must be delivered to or mailed and received at the Company’s principal office on or before May 14, 2025 (without regard to any postponements or adjournments of such meeting after the notice was first given). The notice must include a brief description of the business desired to be brought before the annual meeting, the reasons for conducting such business at the annual